Otonomy, Inc. (OTIC): Price and Financial Metrics


Otonomy, Inc. (OTIC): $0.11

0.00 (3.81%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add OTIC to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

OTIC Stock Price Chart Interactive Chart >

Price chart for OTIC

OTIC Price/Volume Stats

Current price $0.11 52-week high $2.59
Prev. close $0.11 52-week low $0.06
Day low $0.11 Volume 668,488
Day high $0.12 Avg. volume 1,186,245
50-day MA $0.11 Dividend yield N/A
200-day MA $0.85 Market Cap 7.10M

Otonomy, Inc. (OTIC) Company Bio


Otonomy Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear. The company was founded in 2008 and is based in San Diego, California.


OTIC Latest News Stream


Event/Time News Detail
Loading, please wait...

OTIC Latest Social Stream


Loading social stream, please wait...

View Full OTIC Social Stream

Latest OTIC News From Around the Web

Below are the latest news stories about OTONOMY INC that investors may wish to consider to help them evaluate OTIC as an investment opportunity.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday

William White on InvestorPlace | December 21, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tueday

We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Tuesday morning!

William White on InvestorPlace | December 20, 2022

Otonomy Adopts Dissolution & Liquidation Plans, Implements Workforce Reduction

Otonomy Inc's (NASDAQ: OTIC) board of directors has approved and adopted a Plan of Liquidation and Dissolution that would include the distribution of remaining cash to stockholders following an orderly wind-down of the company's operations, including the proceeds from the sale of any pipeline assets. As previously reported, Otonomy initiated an evaluation of strategic options. The company is currently discussing the potential sale of its pipeline assets. Related: At Higher Doses, Otonomy's OTO-4

Yahoo | December 20, 2022

Otonomy Provides Corporate Update

SAN DIEGO, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC) today announced that the company’s board of directors, after considering strategic options, has approved and adopted a Plan of Liquidation and Dissolution (“Plan of Dissolution”) that would include the distribution of remaining cash to stockholders following an orderly wind down of the company’s operations, including the proceeds from the sale of any pipeline assets. To reduce cost, Otonomy has implemented a reduction in w

Yahoo | December 19, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to know about on Thursday!

William White on InvestorPlace | December 15, 2022

Read More 'OTIC' Stories Here

OTIC Price Returns

1-mo 17.52%
3-mo 27.02%
6-mo -68.39%
1-year -94.61%
3-year -96.80%
5-year -97.96%
YTD 26.29%
2022 -95.81%
2021 -67.85%
2020 68.93%
2019 107.03%
2018 -66.67%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7382 seconds.